Skip to content

Author

Fatih Atalah

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

Thymic carcinoma (TC) is a rare and aggressive malignancy with limited evidence guiding second-line treatment after prior systemic therapy. We evaluated real-world outcomes of second-line systemic therapy in a multicenter cohort. Adults with unresectable, recurrent, or metastatic TC who received second-lin...

Fatih Kuş, Fatih Atalah, Gökhan Şahin et al. · 0 citations
2026

Evaluation of AI-Derived Survival Estimates Against Real-World Outcomes in Extensive-Stage Small Cell Lung Cancer

AI-derived survival estimates based on baseline data tend to overestimate survival and show limited agreement with real-world outcomes in extensive-stage SCLC, suggesting these tools may provide general prognostic insight but are not yet suitable for independent clinical decision-making.

Fatih Atalah, M. Gümüş · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.